IceCure Medical Income Statement (2020-2025) | ICCM

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.64M1.38M1.44M0.64M0.68M1.38M0.75M0.77M0.63M0.94M0.71M0.94M0.33M1.25M0.74M1.01M0.66M0.88M0.72M0.53M0.85M
Cost of Revenue 0.19M0.53M0.50M0.38M0.32M0.74M0.31M0.38M0.47M2.04M0.39M0.50M0.35M0.69M0.47M0.48M0.43M0.46M0.51M0.39M0.57M
Gross Profit 0.44M0.85M0.94M0.25M0.36M0.64M0.43M0.38M0.17M0.46M0.32M0.43M-0.02M0.57M0.27M0.53M0.23M0.42M0.22M0.13M0.28M
Operating items
Research & Development 1.00M1.37M1.14M1.59M1.55M1.60M2.39M2.25M2.24M2.24M2.11M2.08M2.20M1.88M1.95M1.58M1.86M1.70M1.66M1.71M1.76M
Selling, General & Administrative 0.44M0.42M0.69M0.89M1.07M1.47M1.72M1.62M1.32M1.19M1.09M1.26M0.92M0.90M0.93M0.92M0.92M0.99M0.92M0.95M1.44M
Operating Expenses 1.45M1.79M1.83M2.48M2.62M3.07M4.11M3.88M3.56M3.43M3.20M3.34M3.12M2.78M2.88M2.50M2.78M2.69M2.59M2.66M3.20M
Operating Income 1.34M-7.10M1.19M2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
EBIT 1.34M-7.10M1.19M2.55M2.85M-16.32M4.42M4.28M4.10M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
Non-operating items
Non Operating Income 0.01M0.43M0.04M-0.31M0.02M0.24M-0.04M-0.46M-0.19M-0.19M-0.12M-0.42M-0.04M-0.15M-0.14M-0.05M-0.07M-0.02M0.02M
Net income details
EBT 1.34M-7.10M1.01M2.63M2.81M-16.32M4.40M4.04M4.14M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
Profit After Tax -1.35M-7.10M-1.37M5.22M-10.58M-3.16M-4.45M13.41M-21.99M-3.95M-3.77M11.43M-19.31M-3.00M-3.61M10.30M-17.53M-4.48M-3.59M10.54M-17.76M
Income from Continuing Operations 1.34M-7.10M1.01M2.63M2.81M-16.32M4.40M4.04M4.14M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
Consolidated Net Income 1.34M-7.10M1.01M2.63M2.81M-16.32M4.40M4.04M4.14M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
Income towards Parent Company 1.34M-7.10M1.01M2.63M2.81M-16.32M4.40M4.04M4.14M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
Net Income towards Common Stockholders 1.34M-7.10M1.01M2.63M2.81M-16.32M4.40M4.04M4.14M-29.55M3.96M4.08M4.12M3.42M3.65M3.23M4.29M4.53M3.66M3.38M3.84M
Additional items
EPS (Basic) 0.01M-0.410.01M0.02M0.01M-0.570.04M0.02M0.01M-0.800.05M0.02M0.02M0.01M0.05M0.02M0.02M0.02M0.06M0.03M0.02M
EPS (Weighted Average and Diluted) 0.09-0.410.050.110.10-0.570.120.110.11-0.800.090.090.090.070.080.02M0.090.090.060.03M0.06
Shares Outstanding (Weighted Average) 196.0017.13M70.00156.00249.0028.55M120.00244.00354.0037.02M80.00170.00260.00320.0080.00140.00220.00300.0060.00120.00180.00
Shares Outstanding (Diluted Average) 15.03M17.13M20.74M24.70M27.10M28.55M36.81M36.81M36.82M37.02M45.62M45.62M45.63M45.64M46.74M140.0049.17M50.88M57.64M120.0060.57M
EBITDA 1.35M-6.68M1.37M2.48M2.89M3.16M4.45M4.52M4.06M3.95M3.77M3.89M4.00M3.00M3.61M3.08M4.15M4.48M3.59M3.36M3.86M
Interest Expenses 0.18M-0.08M0.04M0.02M0.24M-0.04M